RetromanIE
09-07-2011, 16:04
http://nt0.ggpht.com/news/tbn/WG6wUbVfPddgNM/0.jpg
ThirdAge (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)
<img alt="" height="1" width="1" />
SEGA Tumors Respond to mTOR Inhibitor (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIxEN6bs5Fox23rLPGItBoKjh2iw&url=http://www.medpagetoday.com/HematologyOncology/OtherCancers/27466)
MedPage Today
SEGA tumors are a common consequence of tuberous sclerosis, a genetic disease affecting an estimated one to two million people worldwide. "This study, which included SEGA patients from infancy to adulthood, provides compelling evidence of the impact of ...
Novartis' Afinitor reduces SEGA tumour size (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGD3FKO_vw4cqCc21lw5IBF9-0gBw&url=http://www.reuters.com/article/2011/07/08/novartis-idUSLDE76709D20110708)Reuters
Novartis' Afinitor drug meets primary goal of phase 3 trial for TSC drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlxzQ6B7jpIuXAY6hJc95gM5I_8A&url=http://www.proactiveinvestors.com/companies/news/16143/novartis-afinitor-drug-meets-primary-goal-of-phase-3-trial-for-tsc-drug-16143.html)Proactive Investors USA & Canada
Tuberous Sclerosis Complex-Related Tumors Reduced By Afinitor Drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)ThirdAge
FiercePharma (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFa6IcSuJE7-kcVkv8ZT8wspm6Nkg&url=http://www.fiercepharma.com/story/another-study-data-boost-novartis-afinitor/2011-07-08) -RTT News (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEXj-IBER6kxzkbkqqmHV2XyYvupg&url=http://www.rttnews.com/Content/BiotechStory.aspx?Id%3D1661691%26Category%3DClinic alTrial) -PR Newswire (press release) (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFYOgD1ZV1ycJnjDWVNC49ZVzebg&url=http://www.prnewswire.com/news-releases/phase-iii-trial-of-novartis-drug-afinitor-met-primary-endpoint-of-reducing-sega-tumor-size-in-patients-with-tuberous-sclerosis-125198544.html)
all 35 news articles » (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=diPPyGfId81B7JM0-wjrrQDlCHQ4M)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIxEN6bs5Fox23rLPGItBoKjh2iw&url=http://www.medpagetoday.com/HematologyOncology/OtherCancers/27466)
ThirdAge (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)
<img alt="" height="1" width="1" />
SEGA Tumors Respond to mTOR Inhibitor (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIxEN6bs5Fox23rLPGItBoKjh2iw&url=http://www.medpagetoday.com/HematologyOncology/OtherCancers/27466)
MedPage Today
SEGA tumors are a common consequence of tuberous sclerosis, a genetic disease affecting an estimated one to two million people worldwide. "This study, which included SEGA patients from infancy to adulthood, provides compelling evidence of the impact of ...
Novartis' Afinitor reduces SEGA tumour size (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGD3FKO_vw4cqCc21lw5IBF9-0gBw&url=http://www.reuters.com/article/2011/07/08/novartis-idUSLDE76709D20110708)Reuters
Novartis' Afinitor drug meets primary goal of phase 3 trial for TSC drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlxzQ6B7jpIuXAY6hJc95gM5I_8A&url=http://www.proactiveinvestors.com/companies/news/16143/novartis-afinitor-drug-meets-primary-goal-of-phase-3-trial-for-tsc-drug-16143.html)Proactive Investors USA & Canada
Tuberous Sclerosis Complex-Related Tumors Reduced By Afinitor Drug (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHc3lEHwPjH0f2ldnr18F-6LyeZgw&url=http://www.thirdage.com/news/tuberous-sclerosis-complex-related-tumors-reduced-by-afinitor-drug_07-08-2011)ThirdAge
FiercePharma (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFa6IcSuJE7-kcVkv8ZT8wspm6Nkg&url=http://www.fiercepharma.com/story/another-study-data-boost-novartis-afinitor/2011-07-08) -RTT News (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEXj-IBER6kxzkbkqqmHV2XyYvupg&url=http://www.rttnews.com/Content/BiotechStory.aspx?Id%3D1661691%26Category%3DClinic alTrial) -PR Newswire (press release) (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFYOgD1ZV1ycJnjDWVNC49ZVzebg&url=http://www.prnewswire.com/news-releases/phase-iii-trial-of-novartis-drug-afinitor-met-primary-endpoint-of-reducing-sega-tumor-size-in-patients-with-tuberous-sclerosis-125198544.html)
all 35 news articles » (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=diPPyGfId81B7JM0-wjrrQDlCHQ4M)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEIxEN6bs5Fox23rLPGItBoKjh2iw&url=http://www.medpagetoday.com/HematologyOncology/OtherCancers/27466)